StayCurrentMD · Meso-Rex bypass versus portosystemic shunt for the management of extrahepatic portal vein obstruction in children: systematic review and meta-analysis
Article1 min read·Published Dec 2021Older

Meso-Rex bypass versus portosystemic shunt for the management of extrahepatic portal vein obstruction in children: systematic review and meta-analysis

link.springer.com shows its articles on its own site.

Read the article on link.springer.com ↗

Article · Dec 2021 · 1 min read

In brief

In brief

This systematic review and meta-analysis compares meso-Rex bypass (MRB) and portosystemic shunt (PSS) for treating extrahepatic portal vein obstruction in children. Analysis of five observational studies found no significant differences in shunt complications, mortality, or post-operative bleeding between the two approaches, though evidence quality was low and future multicenter trials are needed.

Written by the GCMD Library team from the article.

Abstract

Purpose

Extrahepatic portal vein obstruction (EHPVO) is a major cause of non-cirrhotic portal hypertension in children. Surgical procedures for EHPVO include portosystemic shunts (PSS) and meso-Rex bypass (MRB). We conducted a systematic review and meta-analysis to compare the effectiveness of MRB versus PSS in EHPVO patients.

Methods

A systematic literature search was performed using four databases. Articles reporting EHPVO and comparing patients who received MRB and PSS were included in the analysis.

Results

We retrieved 851 papers, of which five observational studies met the inclusion criteria. There was no difference in shunt complications, mortality, or gastrointestinal bleeding after surgery between MRB and PSS in the meta-analysis. MRB had increased shunt complications compared with PSS in the non-comparative studies. MRB had a potential advantage over PSS in long-term prognosis in one comparative study. Overall, the quality of the evidence was low.

Conclusions

Based on available data, our meta-analysis indicates that MRB does not increase shunt complications, mortality, or gastrointestinal bleeding after surgery. The present study did not reveal superiority for either MRB or PSS. The paucity of well conducted trials in this area justifies future multicenter studies and studies that examine long-term outcomes.

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →